LENA DUNN: Open Payments
NPI 1083126692 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 58 payments from 16 companies in 2025. Trend: 2023 $908 · 2024 $984 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $304 |
| Lilly USA, LLC | 10 | $148 |
| Novo Nordisk Inc | 8 | $138 |
| Gilead Sciences, Inc. | 6 | $115 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Dexcom, Inc. | 1 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Amgen Inc. | 2 | $28 |
| Indivior Inc. | 1 | $28 |
Products named: MOUNJARO, QULIPTA, MAVYRET, VRAYLAR, Rybelsus, LEQVIO, Wegovy, UBRELVY.
Industry payments across FL — which companies pay providers there.
